IRIS
AVENALI, MICOL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.744
AS - Asia 1.419
EU - Europa 1.081
SA - Sud America 309
AF - Africa 84
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.695
CN - Cina 447
SG - Singapore 391
BR - Brasile 235
IE - Irlanda 232
HK - Hong Kong 213
IT - Italia 195
RU - Federazione Russa 184
VN - Vietnam 162
DE - Germania 133
FR - Francia 88
FI - Finlandia 71
ZA - Sudafrica 53
IN - India 50
GB - Regno Unito 48
CA - Canada 27
BD - Bangladesh 22
NL - Olanda 22
AR - Argentina 21
JP - Giappone 20
MX - Messico 19
PL - Polonia 17
CO - Colombia 16
ID - Indonesia 15
IQ - Iraq 13
CZ - Repubblica Ceca 11
SE - Svezia 11
ES - Italia 10
MA - Marocco 10
PK - Pakistan 10
TR - Turchia 10
UA - Ucraina 10
AT - Austria 8
EC - Ecuador 8
JO - Giordania 8
PH - Filippine 8
VE - Venezuela 8
BE - Belgio 7
AL - Albania 6
CL - Cile 6
KG - Kirghizistan 6
MY - Malesia 6
PY - Paraguay 6
UZ - Uzbekistan 6
AU - Australia 5
MO - Macao, regione amministrativa speciale della Cina 5
CH - Svizzera 4
EG - Egitto 4
KE - Kenya 4
SA - Arabia Saudita 4
UY - Uruguay 4
BO - Bolivia 3
CI - Costa d'Avorio 3
KR - Corea 3
KZ - Kazakistan 3
LT - Lituania 3
RO - Romania 3
RS - Serbia 3
SI - Slovenia 3
TN - Tunisia 3
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
MD - Moldavia 1
MM - Myanmar 1
MQ - Martinica 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 4.644
Salva come PNG Salva come JPEG
Città #
Dublin 221
Singapore 213
Chandler 211
Hong Kong 210
San Jose 194
Dallas 169
Ashburn 152
Beijing 122
Boardman 74
Los Angeles 73
Ho Chi Minh City 54
Lauterbourg 50
Helsinki 48
Johannesburg 47
Munich 41
New York 41
Hanoi 37
Milan 37
Shanghai 37
Moscow 36
Princeton 32
Rome 32
Lawrence 30
Medford 28
Redondo Beach 27
Nanjing 26
São Paulo 26
Wilmington 26
Orem 23
Buffalo 19
Santa Clara 19
Frankfurt am Main 18
Turku 18
Tokyo 17
Warsaw 17
Council Bluffs 16
Hebei 16
The Dalles 16
Chennai 14
Nanchang 14
Nuremberg 14
Amsterdam 13
Brooklyn 13
Hangzhou 12
Jacksonville 12
Falkenstein 11
London 11
Pavia 11
Düsseldorf 10
Haiphong 10
Rio de Janeiro 10
Seattle 10
Chicago 9
Fairfield 9
Montreal 9
Shenyang 9
Toronto 9
Amman 8
Changsha 8
Houston 8
Naples 8
Stockholm 8
Ann Arbor 7
Belo Horizonte 7
Boston 7
Brno 7
Columbus 7
Menlo Park 7
Mexico City 7
Norwalk 7
Baghdad 6
Bishkek 6
Da Nang 6
Florence 6
Les Paris 6
Medellín 6
Poplar 6
Pune 6
Tashkent 6
Tianjin 6
Bakersfield 5
Biên Hòa 5
Brussels 5
Denver 5
Elk Grove Village 5
Falls Church 5
Fortaleza 5
Guangzhou 5
Hyderabad 5
Macao 5
Mumbai 5
Phoenix 5
Tirana 5
Tübingen 5
Washington 5
Ankara 4
Atlanta 4
Bogotá 4
Cagliari 4
Camden 4
Totale 2.934
Salva come PNG Salva come JPEG
Nome #
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 148
CLINICAL AND BIOCHEMICAL SIGNATURES OF GBA-RELATED PARKINSON DISEASE 143
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism 129
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 129
Consensus on the treatment of dysphagia in Parkinson's disease 128
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study 124
Time for a consensus conference on pain in neurorehabilitation 120
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 119
KCTD17-related myoclonus-dystonia syndrome: clinical and electrophysiological findings of a patient with atypical late onset 117
Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: A placebo controlled study. 111
Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study 111
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 111
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 110
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project 109
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 109
Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes 108
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 105
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 101
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 101
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 99
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 97
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 93
Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations 92
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 88
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 87
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease 85
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 82
A narrative review on the role and main findings of the Videofluoroscopic Study of Swallowing in Parkison's disease 77
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 76
Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations 67
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 66
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 64
Harmonic ratio is the most responsive trunk-acceleration derived gait index to rehabilitation in people with Parkinson’s disease at moderate disease stages 64
Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects 62
Bilateral Dentate Nuclei Hyperintensities and Response to 4-Aminopyridine in a Patient With Childhood-Onset GAA- FGF14 -Related Ataxia 61
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 59
From DYMUS to DYPARK: Validation of a Screening Questionnaire for Dysphagia in Parkinson’s Disease 59
Pearls & Oy-sters: Marionette Walk in Parkinson Disease 58
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: A 6-year longitudinal study 58
Exploring the neural and behavioral correlates of cognitive telerehabilitation in mild cognitive impairment with three distinct approaches 56
Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) 56
Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial 56
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease 55
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 50
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 50
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants 49
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study 48
Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project 48
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial 48
Functional Study of SNCA p.V15A Variant: Further Linking α-Synuclein and Glucocerebrosidase 47
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort 47
Parkinson disease following COVID-19: Report of six cases 46
Reply to: “Increased alpha-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations” 46
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale 43
Proprioceptive Focal Stimulation (Equistasi®) May Improve the Quality of Gait in Middle-Moderate Parkinson's Disease Patients. Double-Blind, Double-Dummy, Randomized, Crossover, Italian Multicentric Study 42
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 42
Pain in focal dystonias - A focused review to address an important component of the disease 35
Genetic and Epidemiological Insights into RAB32-Linked Parkinson's Disease 31
null 30
Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach 28
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study 23
Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer’s dementia 22
Totale 4.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 4 2 1
2021/2022177 0 1 1 16 9 12 3 13 9 1 20 92
2022/2023566 56 54 5 69 33 44 1 22 256 3 15 8
2023/2024357 37 47 8 22 9 70 29 24 2 11 50 48
2024/20251.129 39 58 21 20 42 116 127 63 259 60 123 201
2025/20262.279 195 190 265 250 285 90 437 139 262 166 0 0
Totale 4.725